A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback